Citation Impact
9 standout
Citing Papers
Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside
2024 Standout
Pseudomonas aeruginosa: Infections, Animal Modeling, and Therapeutics
2023 Standout
Works of Torstein Øverland being referenced
A potential founder variant inCARMIL2/RLTPRin three Norwegian families with warts, molluscum contagiosum, and T-cell dysfunction
2016
Author Peers
| Author | Molecular Biology | Epidemiology | PRM | Immunology | Genetics | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|---|
| Torstein Øverland | 19 | 21 | 9 | 55 | 22 | 5 | 77 | |
| G.H. de Bruijn | 17 | 30 | 8 | 301 | ||||
| Stefan Ziegelmeier | 5 | 8 | 436 | |||||
| Iosif Kapellakis | 6 | 2 | 9 | 302 | ||||
| Nico Oosterhuis | 322 | 1 | 1 | 13 | 15 | 444 | ||
| Anastasia Brooks | 80 | 17 | 19 | 22 | 11 | 7 | 278 |
All Works
Loading papers...